Comprehensive comparison of Pacific Biosciences and Oxford Nanopore Technologies and their applications to transcriptome analysis
Jason L. Weirather(Dana-Farber Cancer Institute), Kin Fai Au(European Bioinformatics Institute)
Cited by 83
Related Papers
Comprehensive comparison of Pacific Biosciences and Oxford Nanopore Technologies and their applications to transcriptome analysis
|F1000Research|2017|514
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
|JAMA Oncology|2020|350
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2024|124
MAPS: pathologist-level cell type annotation from tissue images through machine learning
|Nature Communications|2024|49
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates
|Clinical Cancer Research|2024|35